Potent and Selective Biaryl Amide Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

被引：7

作者：

Sokolsky, Alexander ^{[1
]}

Vechorkin, Oleg ^{[1
]}

Hummel, Joshua R. ^{[1
]}

Styduhar, Evan D. ^{[1
]}

Wang, Anlai ^{[1
]}

Nguyen, Minh H. ^{[1
]}

Ye, Hai Fen ^{[1
]}

Liu, Kai ^{[1
]}

Zhang, Ke ^{[1
]}

Pan, Jun ^{[1
]}

Ye, Qinda ^{[1
]}

Atasoylu, Onur ^{[1
]}

Behshad, Elham ^{[1
]}

He, Xin ^{[1
]}

Conlen, Patricia ^{[1
]}

Stump, Kristine ^{[1
]}

Ye, Min ^{[1
]}

Diamond, Sharon ^{[1
]}

Covington, Maryanne ^{[1
]}

Yeleswaram, Swamy ^{[1
]}

Yao, Wenqing ^{[1
]}

机构：

[1] Incyte Res Inst, Wilmington, DE 19803 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2023年 / 14卷 / 01期

关键词：

HPK1; tyrosine kinase inhibition; selectivity profile; STK4; TARGET; IMMUNOLOGY; IMMUNITY;

D O I：

10.1021/acsmedchemlett.2c00241

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Herein we report the discovery of a novel biaryl amide series as selective inhibitors of hematopoietic protein kinase 1 (HPK1). Structure-activity relationship development, aided by molecular modeling, identified indazole 5b as a core for further exploration because of its outstanding enzymatic and cellular potency coupled with encouraging kinome selectivity. Late-stage manipulation of the right-hand aryl and amine moieties surmounted issues of selectivity over TRKA, MAP4K2, and STK4 as well as generating compounds with balanced in vitro ADME profiles and promising pharmacokinetics.

引用

页码：116 / 122

页数：7

共 50 条

[41] Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3
Golkowski, Martin
Perera, Gayani K.
Vidadala, Venkata Narayana
Ojo, Kayode K.
Van Voorhis, Wesley C.
Maly, Dustin J.
Ong, Shao-En
MOLECULAR OMICS, 2018, 14 (01) : 26 - 36
[42] Development of potent and selective ULK1/2 inhibitors based on 7-azain-dole scaffold with favorable in vivo properties
Morozova, Alisa
Chan, Sean Chin
Bayle, Simon
Sun, Luxin
Grassie, Dylan
Iermolaieva, Anna
Kalaga, Mahalakshmi N.
Frydman, Sylvia
Sansil, Samer
Scho, Ernst
Duckett, Derek
Monastyrskyi, Andrii
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 266
[43] Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight
Toure, B. Barry
Giraldes, John
Smith, Troy
Sprague, Elizabeth R.
Wang, Yaping
Mathieu, Simon
Chen, Zhuoliang
Mishina, Yuji
Feng, Yun
Yan-Neale, Yan
Shakya, Subarna
Chen, Dongshu
Meyer, Matthew
Puleo, David
Brazell, J. Tres
Straub, Christopher
Sage, David
Wright, Kirk
Yuan, Yanqiu
Chen, Xin
Duca, Jose
Kim, Sean
Tian, Li
Martin, Eric
Hurov, Kristen
Shao, Wenlin
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (10) : 4711 - 4723
[44] Discovery and Optimization of a Series of Benzofuran Selective ERAP1 Inhibitors: Biochemical and In Silico Studies
Deddouche-Grass, Safia
Andouche, Cyrielle
Barenz, Felix
Halter, Celia
Hohwald, Arnaud
Lebrun, Louison
Membre, Nathalie
Morales, Renaud
Muzet, Nicolas
Poirot, Matthieu
Reynaud, Morgane
Roujean, Veronique
Weber, Fabienne
Zimmermann, Andre
Heng, Rama
Basse, Nicolas
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (07): : 1137 - 1142
[45] Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity
Yang, Shyh-Ming
Martinez, Natalia J.
Yasgar, Adam
Danchik, Carina
Johansson, Catrine
Wang, Yuhong
Baljinnyam, Bolormaa
Wang, Amy Q.
Xu, Xin
Shah, Pranav
Chef, Dorian
Wang, Xinran S.
Roth, Jacob
Lal-Nag, Madhu
Dunford, James E.
Oppermann, Udo
Vasiliou, Vasilis
Simeonov, Anton
Jadhav, Ajit
Maloney, David J.
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (11) : 4883 - 4903
[46] The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase
Malagu, Karine
Duggan, Heather
Menear, Keith
Hummersone, Marc
Gomez, Sylvie
Bailey, Christine
Edwards, Peter
Drzewiecki, Jan
Leroux, Frederic
Quesada, Mar Jimenez
Hermann, Gesine
Maine, Stephanie
Molyneaux, Carrie-Anne
Le Gall, Armelle
Pullen, James
Hickson, Ian
Smith, Lisa
Maguire, Sharon
Martin, Niall
Smith, Graeme
Pass, Martin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5950 - 5953
[47] Structure-guided identification of potent inhibitors of ROS1 kinase for therapeutic development against non-small cell lung cancer
Khan, Mohd Shahnawaz
Altwaijry, Nojood
Al-Bagmi, Moneera Saud
Alafaleq, Nouf Omar
Alokail, Majed S.
Shahwan, Moyad
Shamsi, Anas
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (08): : 3837 - 3847
[48] Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B
Segretti, Natanael D.
Takarada, Jessica E.
Ferreira, Marcos A., Jr.
Santiago, Andre da Silva
Teodoro, Bruno V. M.
Damiao, Mariana C. F. C. B.
Godoi, Paulo H.
Cunha, Micael R.
Fala, Angela M.
Ramos, Priscila Z.
Ishikawa, Eloisa E.
Mascarello, Alessandra
Serafim, Ricardo A. M.
Azevedo, Hatylas
Guimaraes, Cristiano R. W.
Counago, Rafael M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 68
[49] In silico screening of a series of 1,6-disubstituted 1H-pyrazolo[3,4-d]pyrimidines as potential selective inhibitors of the Janus kinase 3
Faris, Abdelmoujoud
Hadni, Hanine
Saleh, Basil A.
Khelfaoui, Hadjer
Harkati, Dalal
Ait Ahsaine, Hassan
Elhallaoui, Menana
El-Hiti, Gamal A.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, : 4456 - 4474
[50] BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells
Lian, Guodong
Li, Leping
Shi, Yulong
Jing, Changqing
Liu, Jinglei
Guo, Xiaobo
Zhang, Qingqing
Dai, Tianyu
Ye, Fei
Wang, Yanyan
Chen, Man
INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) : 804 - 814

← 1 2 3 4 5 →